Enovix Corporation (NASDAQ:ENVX) Shares Purchased by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. raised its stake in shares of Enovix Corporation (NASDAQ:ENVX) by 8.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 300,970 shares of the company’s stock after buying an additional 22,208 shares during the quarter. Oppenheimer & Co. Inc. owned about 0.16% of Enovix worth $2,209,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the business. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Enovix by 15.5% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 67,088 shares of the company’s stock worth $492,000 after purchasing an additional 9,024 shares during the last quarter. Refined Wealth Management boosted its holdings in shares of Enovix by 18.8% during the first quarter. Refined Wealth Management now owns 675,449 shares of the company’s stock worth $4,958,000 after purchasing an additional 106,843 shares during the last quarter. Register Financial Advisors LLC boosted its holdings in shares of Enovix by 52.3% during the first quarter. Register Financial Advisors LLC now owns 266,336 shares of the company’s stock worth $1,955,000 after purchasing an additional 91,486 shares during the last quarter. Merrion Investment Management Co LLC boosted its holdings in shares of Enovix by 15.9% during the first quarter. Merrion Investment Management Co LLC now owns 37,930 shares of the company’s stock worth $278,000 after purchasing an additional 5,200 shares during the last quarter. Finally, Fortis Advisors LLC acquired a new stake in shares of Enovix during the first quarter worth $90,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Trading Up 20.8%

NASDAQ:ENVX opened at $10.53 on Friday. The business’s 50-day moving average is $7.64 and its two-hundred day moving average is $8.87. The company has a debt-to-equity ratio of 0.71, a current ratio of 4.68 and a quick ratio of 4.49. Enovix Corporation has a 12 month low of $5.27 and a 12 month high of $18.68. The firm has a market capitalization of $2.02 billion, a PE ratio of -8.16 and a beta of 2.00.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on ENVX shares. B. Riley decreased their price objective on Enovix from $17.00 to $12.00 and set a “buy” rating on the stock in a report on Tuesday, April 29th. Benchmark decreased their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, April 15th. JPMorgan Chase & Co. cut their target price on Enovix from $10.00 to $9.00 and set an “overweight” rating on the stock in a research report on Thursday, May 1st. Finally, TD Securities cut their target price on Enovix from $10.00 to $7.00 and set a “hold” rating on the stock in a research report on Thursday, May 1st. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, Enovix currently has an average rating of “Moderate Buy” and a consensus target price of $17.27.

About Enovix

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.